Concepedia

Kongfei Li

KL

9

Publications

272

Citations

9

H-Index

2014

Active since

Affiliations

Zhejiang University(Current)

Ningbo University

First Affiliated Hospital of Zhengzhou University

Ningbo No. 2 Hospital

First Affiliated Hospital Zhejiang University

Kongfei Li is an author at Zhejiang University specializing in cell death, tumor biology, and dna methylation.

ORCID

Top concepts

Publications per year

2014–2024

9

Publications

9

E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway

Yan Yu, Dan Zhao, Kongfei Li et al. · Cell Death and Disease · 2020 · 75 citations · Full text

Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear target

Kongfei Li, Chao Hu, Chen Mei et al. · Journal of Translational Medicine · 2014 · 48 citations · Full text

CBX2 is a functional target of miRNA let‐7a and acts as a tumor promoter in osteosarcoma

Qicai Han, Chao Li, Yuan Cao et al. · Cancer Medicine · 2019 · 31 citations · Full text

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370

Yan Yu, Penglin Xu, Guangying Cui et al. · Cancer Cell International · 2020 · 26 citations · Full text

PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

Chao Hu, Mengxia Yu, Yanling Ren et al. · Scientific Reports · 2017 · 22 citations · Full text

Rows per page

1–5 of 9